Loading…

Quantifying immune-based counterselection of somatic mutations

Somatic mutations in protein-coding regions can generate 'neoantigens' causing developing cancers to be eliminated by the immune system. Quantitative estimates of the strength of this counterselection phenomenon have been lacking. We quantified the extent to which somatic mutations are dep...

Full description

Saved in:
Bibliographic Details
Published in:PLoS genetics 2019-07, Vol.15 (7), p.e1008227-e1008227
Main Authors: Yang, Fan, Kim, Dae-Kyum, Nakagawa, Hidewaki, Hayashi, Shuto, Imoto, Seiya, Stein, Lincoln, Roth, Frederick P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Somatic mutations in protein-coding regions can generate 'neoantigens' causing developing cancers to be eliminated by the immune system. Quantitative estimates of the strength of this counterselection phenomenon have been lacking. We quantified the extent to which somatic mutations are depleted in peptides that are predicted to be displayed by major histocompatibility complex (MHC) class I proteins. The extent of this depletion depended on expression level of the neoantigenic gene, and on whether the patient had one or two MHC-encoding alleles that can display the peptide, suggesting MHC-encoding alleles are incompletely dominant. This study provides an initial quantitative understanding of counter-selection of identifiable subclasses of neoantigenic somatic variation.
ISSN:1553-7404
1553-7390
1553-7404
DOI:10.1371/journal.pgen.1008227